Worth Venture Partners, LLC - HTG MOLECULAR DIAGNOSTICS IN ownership

Back to all holdings Add to watchlist

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 24 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Worth Venture Partners, LLC ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q4 2021$776,000
-5.0%
143,1350.0%0.38%
+4.3%
Q3 2021$817,000
-1.8%
143,1350.0%0.37%
+18.7%
Q2 2021$832,000
+178.3%
143,135
+161.4%
0.31%
+113.8%
Q1 2021$299,000–54,747–0.14%–
 Download
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q3 2021
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 6,966$7,0000.01%
TWO SIGMA SECURITIES, LLC 57,454$59,0000.00%
Virtu Financial LLC 13,127$14,0000.00%
UBS Group AG 26$00.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 60$00.00%
OSAIC HOLDINGS, INC. 13$00.00%
WELLS FARGO & COMPANY/MN 50$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 47,178$48,0000.00%
STATE STREET CORP 14,455$15,0000.00%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders